Novel targeted therapy could be effective treatment option for deadly childhood cancer

RICHMOND, Va. — New research from VCU Massey Cancer Center — published this week in Cell Reports — demonstrated that a novel targeted therapy could be an effective treatment option

Related Keywords

Virginia ,United States ,Richmond ,America ,Regina Egan ,Cyril Benes ,Giordano Caponigro ,Richard Kurupi ,Joseph Mcclanaghan ,Anthony Faber ,Jinyang Cai ,Ellen Murchie ,Huaixiang Hao ,Kentaro Hirade ,Johnr Congdon ,Patricia Greninger ,Krista Powell ,Yuta Adachi ,Sosipatros Boikos ,Sheeba Jacob ,Mikhail Dozmorov ,Colin Coon ,Hiromichi Ebi ,Giovanna Stein ,School Of Medicine ,National Cancer Institute ,Georgetown University Medical Center ,Harvard Medical School ,School Of Dentistry ,Novartis Institute Of Biological Research ,Cancer Research ,Philips Institute For Oral Health Research ,Collaborative Pediatric Cancer Research Awards Program ,Aichi Cancer Center Research Institute ,Massey Cancer Center ,Cancer Center Support Grant ,Cancer Center ,Cell Reports ,Developmental Therapeutics ,Endowed Chair ,Philips Institute ,Oral Health Research ,Cancer Mouse Models Core ,John Glod ,National Cancer ,Cancer Biology ,Novartis Institute ,News ,